Characteristic | Placebo (n = 40) | NAC + DFX (n = 40) |
---|---|---|
Age, years, mean ± SD | 56 ± 14 | 51 ± 16 |
Male sex, n (%) | 23 (57) | 20 (50) |
Charlson comorbidity score, mean ± SD | 2.4 ± 2.1 | 2.6 ± 2.3 |
Medical admission, n (%) | 33 (82) | 32 (80) |
Sepsis at enrollment, n (%) | 20 (50) | 21 (52) |
Cardiogenic shock, n (%) | 10 (25) | 9 (22) |
Trauma, n (%) | 6 (15) | 7 (17) |
APACHE II score, mean ± SD | 19 ± 7 | 20 ± 7 |
SOFA score day 1, mean ± SD | 9.4 ± 4 | 9.3 ± 3.7 |
Creatinine at enrollment, mean ± SD | 1.0 ± 0.6 | 1.2 ± 1.7 |
AKI at admission, yes, n (%) | 14 (35) | 12 (30) |
Mechanical ventilation at enrolment, yes, n (%) | 25 (62) | 23 (58) |
Need for vasoactive drug, yes, n (%) | 34 (85) | 35 (87) |